Morning Market Gainers

(NASDAQ:

) shares jumped 30.99 percent to $1.72. Onconova Therapeutics presented positive data Monday from Phase 2 combination trial of oral Rigosertib And Azacitidine at the ASH 2015.

(NYSEMKT: TXMD) shares gained 30.17 percent to $8.50 after the company reported positive top-line results from its pivotal Phase 3 Rejoice trial of TX-004HR.

(NASDAQ:

) shares jumped 12.88 percent to $92.47 after the company announced receiving $15 million milestone.

(NASDAQ:

) shares gained 11.81 percent to $3.69. On Monday, Technical Communications reported a net loss of $(0.64) per share, on revenue of $931,000 for the quarter ended October 3, 2015.

(NASDAQ:

) shares surged 10.82 percent to $6.35. MFRI reported Q3 earnings of $0.83 per share on sales of $66.316 million.

(NASDAQ:

) shares gained 8.51 percent to $1.39 after the company reported review of strategic alternatives.

(NASDAQ:

) shares rose 5.73 percent to $20.65 after the company announced the receipt of an unsolicited bid to be acquired for $21.70 per share in cash.

(NASDAQ:

) shares surged 4.64 percent to $1.58 after the company reported upbeat Q3 earnings.

(NASDAQ:

) shares gained 2.63 percent to $20.72. Citigroup upgraded FireEye from Neutral to Buy and raised the price target from $31.00 to $35.00.